Crosstide is a peptide analog of glycogen synthase kinase α/β fusion protein sequence which is a substrate for Akt.
CAT No: R1308
CAS No:171783-05-4
Synonyms/Alias:Crosstide;171783-05-4;Crosstide (trifluoroacetate salt);MFCD03787963;DTXSID60432141;AS-85941;Glycyl-L-arginyl-L-prolyl-L-arginyl-L-threonyl-L-seryl-L-seryl-L-phenylalanyl-L-alanyl-L-alpha-glutamylglycine;A11762;Crosstide, >=97% (HPLC), lyophilized powder;(4S)-4-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-(2-AMINOACETAMIDO)-5-CARBAMIMIDAMIDOPENTANOYL]PYRROLIDIN-2-YL]FORMAMIDO}-5-CARBAMIMIDAMIDOPENTANAMIDO]-3-HYDROXYBUTANAMIDO]-3-HYDROXYPROPANAMIDO]-3-HYDROXYPROPANAMIDO]-3-PHENYLPROPANAMIDO]PROPANAMIDO]-4-(CARBOXYMETHYLCARBAMOYL)BUTANOIC ACID;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.